Cargando…

Functional outcome of prolonged refractory status epilepticus

INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Alexandre, Outin, Hervé D, Jabot, Julien, Mégarbane, Bruno, Gaudry, Stéphane, Coudroy, Rémi, Louis, Guillaume, Schneider, Francis, Barbarot, Nicolas, Roch, Antoine, Lerolle, Nicolas, Luis, David, Fourrier, François, Renault, Anne, Argaud, Laurent, Sharshar, Tarek, Gibot, Sébastien, Bollaert, Pierre-Edouard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426536/
https://www.ncbi.nlm.nih.gov/pubmed/25925042
http://dx.doi.org/10.1186/s13054-015-0914-9
_version_ 1782370596066164736
author Lai, Alexandre
Outin, Hervé D
Jabot, Julien
Mégarbane, Bruno
Gaudry, Stéphane
Coudroy, Rémi
Louis, Guillaume
Schneider, Francis
Barbarot, Nicolas
Roch, Antoine
Lerolle, Nicolas
Luis, David
Fourrier, François
Renault, Anne
Argaud, Laurent
Sharshar, Tarek
Gibot, Sébastien
Bollaert, Pierre-Edouard
author_facet Lai, Alexandre
Outin, Hervé D
Jabot, Julien
Mégarbane, Bruno
Gaudry, Stéphane
Coudroy, Rémi
Louis, Guillaume
Schneider, Francis
Barbarot, Nicolas
Roch, Antoine
Lerolle, Nicolas
Luis, David
Fourrier, François
Renault, Anne
Argaud, Laurent
Sharshar, Tarek
Gibot, Sébastien
Bollaert, Pierre-Edouard
author_sort Lai, Alexandre
collection PubMed
description INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive care units in French university and general hospitals. Patients were adults with a generalized convulsive refractory status epilepticus that lasted more than seven days, despite treatment including an anesthetic drug and mechanical ventilation. Patients with anoxic encephalopathy were excluded. Follow-up phone call was used to determine functional outcome using modified Rankin Scale (mRS) with mRS 0–3 defining good and mRS 4–6 poor outcome. RESULTS: 78 patients (35 female) were included. Median age was 57 years. Causes of status epilepticus were various, mainly including prior epilepsy (14.1%), CNS infection (12.8%), and stroke (12.8%). No etiology was found in 27 (34.6%) patients. PRSE was considered controlled in only 53 (67.9%) patients after a median duration of 17 (IQR 12–26) days. The median length of ICU stay was 28 (19–48) days. Forty-one (52.5%) patients died in the ICU, 26 from multiple organ failure, 8 from care withdrawal, 2 from sudden cardiac arrest, 1 from brain death and 4 from unknown causes. PRSE was previously resolved in 20 patients who died in the ICU. At one-year follow-up, there were 12 patients with good outcome and 58 with poor outcome and 8 lost of follow-up. On multivariate analysis, only vasopressor use was a predictor of poor outcome (OR 6.54; 95%CI 1.09-39.29; p = 0.04). CONCLUSION: Poor outcome was observed in about 80% of this population of PRSE. Most patients died from systemic complications linked to their ICU stay. Some patients can recover satisfactorily over time though we did not identify any robust factor of good outcome.
format Online
Article
Text
id pubmed-4426536
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44265362015-05-12 Functional outcome of prolonged refractory status epilepticus Lai, Alexandre Outin, Hervé D Jabot, Julien Mégarbane, Bruno Gaudry, Stéphane Coudroy, Rémi Louis, Guillaume Schneider, Francis Barbarot, Nicolas Roch, Antoine Lerolle, Nicolas Luis, David Fourrier, François Renault, Anne Argaud, Laurent Sharshar, Tarek Gibot, Sébastien Bollaert, Pierre-Edouard Crit Care Research INTRODUCTION: To characterize etiology, clinical course and outcomes of patients in prolonged refractory status epilepticus (PRSE) and looking for prognostic factors. METHODS: Retrospective study conducted in patients hospitalized from January 1, 2001 to December 31, 2011 in 19 polyvalent intensive care units in French university and general hospitals. Patients were adults with a generalized convulsive refractory status epilepticus that lasted more than seven days, despite treatment including an anesthetic drug and mechanical ventilation. Patients with anoxic encephalopathy were excluded. Follow-up phone call was used to determine functional outcome using modified Rankin Scale (mRS) with mRS 0–3 defining good and mRS 4–6 poor outcome. RESULTS: 78 patients (35 female) were included. Median age was 57 years. Causes of status epilepticus were various, mainly including prior epilepsy (14.1%), CNS infection (12.8%), and stroke (12.8%). No etiology was found in 27 (34.6%) patients. PRSE was considered controlled in only 53 (67.9%) patients after a median duration of 17 (IQR 12–26) days. The median length of ICU stay was 28 (19–48) days. Forty-one (52.5%) patients died in the ICU, 26 from multiple organ failure, 8 from care withdrawal, 2 from sudden cardiac arrest, 1 from brain death and 4 from unknown causes. PRSE was previously resolved in 20 patients who died in the ICU. At one-year follow-up, there were 12 patients with good outcome and 58 with poor outcome and 8 lost of follow-up. On multivariate analysis, only vasopressor use was a predictor of poor outcome (OR 6.54; 95%CI 1.09-39.29; p = 0.04). CONCLUSION: Poor outcome was observed in about 80% of this population of PRSE. Most patients died from systemic complications linked to their ICU stay. Some patients can recover satisfactorily over time though we did not identify any robust factor of good outcome. BioMed Central 2015-04-30 2015 /pmc/articles/PMC4426536/ /pubmed/25925042 http://dx.doi.org/10.1186/s13054-015-0914-9 Text en © Lai et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lai, Alexandre
Outin, Hervé D
Jabot, Julien
Mégarbane, Bruno
Gaudry, Stéphane
Coudroy, Rémi
Louis, Guillaume
Schneider, Francis
Barbarot, Nicolas
Roch, Antoine
Lerolle, Nicolas
Luis, David
Fourrier, François
Renault, Anne
Argaud, Laurent
Sharshar, Tarek
Gibot, Sébastien
Bollaert, Pierre-Edouard
Functional outcome of prolonged refractory status epilepticus
title Functional outcome of prolonged refractory status epilepticus
title_full Functional outcome of prolonged refractory status epilepticus
title_fullStr Functional outcome of prolonged refractory status epilepticus
title_full_unstemmed Functional outcome of prolonged refractory status epilepticus
title_short Functional outcome of prolonged refractory status epilepticus
title_sort functional outcome of prolonged refractory status epilepticus
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426536/
https://www.ncbi.nlm.nih.gov/pubmed/25925042
http://dx.doi.org/10.1186/s13054-015-0914-9
work_keys_str_mv AT laialexandre functionaloutcomeofprolongedrefractorystatusepilepticus
AT outinherved functionaloutcomeofprolongedrefractorystatusepilepticus
AT jabotjulien functionaloutcomeofprolongedrefractorystatusepilepticus
AT megarbanebruno functionaloutcomeofprolongedrefractorystatusepilepticus
AT gaudrystephane functionaloutcomeofprolongedrefractorystatusepilepticus
AT coudroyremi functionaloutcomeofprolongedrefractorystatusepilepticus
AT louisguillaume functionaloutcomeofprolongedrefractorystatusepilepticus
AT schneiderfrancis functionaloutcomeofprolongedrefractorystatusepilepticus
AT barbarotnicolas functionaloutcomeofprolongedrefractorystatusepilepticus
AT rochantoine functionaloutcomeofprolongedrefractorystatusepilepticus
AT lerollenicolas functionaloutcomeofprolongedrefractorystatusepilepticus
AT luisdavid functionaloutcomeofprolongedrefractorystatusepilepticus
AT fourrierfrancois functionaloutcomeofprolongedrefractorystatusepilepticus
AT renaultanne functionaloutcomeofprolongedrefractorystatusepilepticus
AT argaudlaurent functionaloutcomeofprolongedrefractorystatusepilepticus
AT sharshartarek functionaloutcomeofprolongedrefractorystatusepilepticus
AT gibotsebastien functionaloutcomeofprolongedrefractorystatusepilepticus
AT bollaertpierreedouard functionaloutcomeofprolongedrefractorystatusepilepticus